Myeloproliferative Disorders and Myelodysplastic Syndromes
作者： Jo-Anne Vergilio , Adam Bagg
DOI: 10.1007/978-0-387-33227-7_35
关键词:
摘要: The myeloproliferative disorders (MPD) and myelodysplastic syndromes (MDS) encompass a pathologically clinically heterogeneous group of hematologic entities that are united by their putative origin from pluripotent hematopoietic stem cells. World Health Organization classifies these into three broad categories: (1) the chronic diseases, (2) syndromes, (3) myelodysplastic/myeloproliferative diseases1 (see Table 35-1). Though all true cell characteristically associated with bone marrow hyperplasia, they divergent in MPD typically effective hematopoiesis, while MDS ineffective reflected high or low peripheral blood counts, respectively.
springer.com
sci-hub.st 参考文章(105)
M. Flactif, E. Wattel, P. Fenaux, P. Lepelley, C. Preudhomme, M. Zandecki, M. Vanrumbeke, J.-L. Lai, Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. Leukemia. ,vol. 9, pp. 370- 381 ,(1995)
Adam Bagg, Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring. The Journal of Molecular Diagnostics. ,vol. 4, pp. 1- 10 ,(2002) , 10.1016/S1525-1578(10)60675-7
R E Gale, Evaluation of clonality in myeloid stem-cell disorders. Seminars in Hematology. ,vol. 36, pp. 361- 372 ,(1999)
H. Y. Zoghbi, Howard Rosenblatt, J. W. Belmont, A. B. Moseley, R. C. Allen, Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics. ,vol. 51, pp. 1229- 1239 ,(1992)
Shikha Bose, Michael Deininger, Joanna Gora-Tybor, John M Goldman, Junia V Melo, None, The Presence of Typical and Atypical BCR-ABL Fusion Genes in Leukocytes of Normal Individuals: Biologic Significance and Implications for the Assessment of Minimal Residual Disease Blood. ,vol. 92, pp. 3362- 3367 ,(1998) , 10.1182/BLOOD.V92.9.3362
Jürgen Fuchs, Encyclopedia of Medical Genomics and Proteomics CRC Press. ,(2004) , 10.1081/E-EMGP
Josefina Serrano, Jose Roman, Joaquin Sanchez, Antonio Jimenez, Juan A. Castillejo, Concepcion Herrera, Maria Gracia Gonzalez, Luisa Reina, Maria del Carmen Rodriguez, Miguel A. Alvarez, Juan Maldonado, Antonio Torres, Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190BCR-ABL detection precede cytogenetic relapse Blood. ,vol. 95, pp. 2659- 2665 ,(2000) , 10.1182/BLOOD.V95.8.2659.008K21_2659_2665
JP Radich, G Gehly, T Gooley, E Bryant, RA Clift, S Collins, S Edmands, J Kirk, A Lee, P Kessler, Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients Blood. ,vol. 85, pp. 2632- 2638 ,(1995) , 10.1182/BLOOD.V85.9.2632.BLOODJOURNAL8592632
Jean-Claude Chomel, Françoise Brizard, Anne Veinstein, Jérôme Rivet, Alain Sadoun, Alain Kitzis, François Guilhot, André Brizard, Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone marrow transplantation Blood. ,vol. 95, pp. 404- 408 ,(2000) , 10.1182/BLOOD.V95.2.404
NJ White, E Nacheva, FA Asimakopoulos, D Bloxham, B Paul, AR Green, Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood. ,vol. 83, pp. 2809- 2816 ,(1994) , 10.1182/BLOOD.V83.10.2809.2809